These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1115 related items for PubMed ID: 16262756

  • 1. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H, Watanabe T, Nakagawa R, Watanabe H, Okamoto Y, Onishi T, Abe T, Kawano Y, Kagami S, Takaue Y.
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [Abstract] [Full Text] [Related]

  • 2. Predictive parameters for granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
    Okano A, Ashihara E, Shimazaki C, Uchiyama H, Inaba T, Taniguchi K, Maekawa T, Taniwaki M.
    J Clin Apher; 2008 Nov; 23(6):171-7. PubMed ID: 18988229
    [Abstract] [Full Text] [Related]

  • 3. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation.
    Díaz MA, Sevilla J, de la Rubia J, Verdeguer A, Espigado I, Vicent MG, Pascual MJ, Zamora C, Arrieta R, Serrano D, del Cañizo C, Arbona C, de Arriba F, Bargay J, Brunet S, Sanz MA.
    Haematologica; 2003 Aug; 88(8):919-22. PubMed ID: 12935980
    [Abstract] [Full Text] [Related]

  • 4. Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings.
    Wang TF, Wen SH, Chen RL, Lu CJ, Zheng YJ, Yang SH, Chu SC, Kao RH, Chen SH.
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1305-11. PubMed ID: 18940686
    [Abstract] [Full Text] [Related]

  • 5. Factors affecting PBSC mobilization and collection in healthy donors.
    Lysák D, Koza V, Jindra P.
    Transfus Apher Sci; 2005 Nov; 33(3):275-83. PubMed ID: 16209935
    [Abstract] [Full Text] [Related]

  • 6. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK, Kim JG, Seo KW, Chae YS, Jung JT, Suh JS, Lee KB.
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [Abstract] [Full Text] [Related]

  • 7. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
    Ings SJ, Balsa C, Leverett D, Mackinnon S, Linch DC, Watts MJ.
    Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R.
    Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors.
    Kawano Y, Takaue Y, Watanabe T, Abe T, Okamoto Y, Iwai A, Iwai T, Watanabe A, Ito E, Makimoto A, Nakagawa R, Watanabe H, Sato J, Suenaga K, Suzuya H, Ohnishi T, Kanamaru S, Kaneko M, Kuroda Y.
    Cancer Res; 1999 Jul 15; 59(14):3321-4. PubMed ID: 10416586
    [Abstract] [Full Text] [Related]

  • 10. Predictive factors that affect the mobilization of CD34(+) cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF).
    Martino M, Callea I, Condemi A, Dattola A, Irrera G, Marcuccio D, Messina G, Pontari A, Pucci G, Console G, Lacopino P.
    J Clin Apher; 2006 Oct 15; 21(3):169-75. PubMed ID: 16532489
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxic drug and cytotoxic drug/G-CSF mobilization of peripheral blood stem cells and their use for autografting.
    Teshima T, Harada M, Takamatsu Y, Makino K, Taniguchi S, Inaba S, Kondo S, Tanaka T, Akashi K, Minamishima I.
    Bone Marrow Transplant; 1992 Sep 15; 10(3):215-20. PubMed ID: 1384898
    [Abstract] [Full Text] [Related]

  • 12. [CD34 cells and T cell subsets in recombinant human granulocyte colony-stimulating factor primed bone marrow grafts from donors with different characteristics].
    Chang YJ, Zhao XY, Huo MR, Luo XH, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Aug 15; 29(8):512-6. PubMed ID: 19112912
    [Abstract] [Full Text] [Related]

  • 13. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I, Cepulić BG, Mazić S.
    Acta Med Croatica; 2009 Jun 15; 63(3):237-44. PubMed ID: 19827352
    [Abstract] [Full Text] [Related]

  • 14. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 15; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 15. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H, Watanabe T, Suzuya H, Wakata Y, Kaneko M, Onishi T, Okamoto Y, Abe T, Kawano Y, Kagami S, Takaue Y.
    Bone Marrow Transplant; 2006 Apr 15; 37(7):661-8. PubMed ID: 16489358
    [Abstract] [Full Text] [Related]

  • 16. Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.
    Yang SH, Wang TF, Tsai HH, Lin TY, Wen SH, Chen SH.
    Transfusion; 2010 May 15; 50(5):1088-95. PubMed ID: 20051055
    [Abstract] [Full Text] [Related]

  • 17. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH, Schulman KA, Buckner CD.
    Bone Marrow Transplant; 2001 May 15; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [Abstract] [Full Text] [Related]

  • 18. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation.
    Kröger N, Renges H, Krüger W, Gutensohn K, Löliger C, Carrero I, Cortes L, Zander AR.
    Br J Haematol; 2000 Dec 15; 111(3):761-5. PubMed ID: 11122135
    [Abstract] [Full Text] [Related]

  • 19. Harvesting peripheral blood progenitor cells from healthy donors with a short course of recombinant human granulocyte-colony-stimulating factor.
    Martino M, Morabito F, Callea I, Pontari A, Irrera G, Pucci G, Dattola A, Messina G, Console G, Iacopino P.
    Transfus Med; 2005 Aug 15; 15(4):323-8. PubMed ID: 16101811
    [Abstract] [Full Text] [Related]

  • 20. Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimen.
    Dawson MA, Schwarer AP, Muirhead JL, Bailey MJ, Bollard GM, Spencer A.
    Bone Marrow Transplant; 2005 Sep 15; 36(5):389-96. PubMed ID: 15980882
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 56.